46 | Вестник «МЕДСИ» | Лекция для практикующих врачей
проблемы лечения боли и необходимости организации такой структуры. Полагаю, что при дальнейшей поддержке и развитии организованный Центр боли в рамках мультидисциплинарного медицинского комплекса «МЕДСИ» может стать лидером в России по проблеме лечения боли и сделать существенный вклад в решение сложной задачи лечения и реабилитации людей, страдающих от боли. K
Литература 1. Collard HR; Schwarz MI. Diffuse alveolar hemorrhage. Clin 1. Б о левые синдромы в неврологической практике // Под ред. Вейна А.М. – М.: МЕДпресс-информ. – 2010. 2. Болезни нервной системы // Под ред. Яхно Н.Н., Штульмана Д.Р. – М.: Медицина,. – 2002. 3. Данилов А.Б., Давыдов О.С. Нейропатическая боль. – М.: Боргес. – 2007. – 198 C. 4. Bonica J.J. The Management of Pain, with Special Emphasis on the Use of Block in Diagnosis, Prognosis and Therapy. Philadelphia, PA: Lea & Febiger. – 1953. 5. Melzack R., Wall P.D. Pain mechanisms: A new theory. Science. – 1965. – 150 (699):971–9. 6. Melzack R. From the gate to the neuromatrix. Pain. – 1999. – 82 (suppl 6). – р. – 121–6. 7. Cervero F., Meyer R.A., Campbell J.N. A psychophysical study of secondary hyperalgesia: Evidence for increased pain to input from nociceptors. Pain. – 1994. – 58 (1):21–8. 8. Campbell J.N., Meyer R.A. Mechanisms of neuropathic pain. Neuron. – 2006. – 52 (1):77–92. 9. Cheng H.Y., Penninger J.M. When the DREAM is gone: From basic science to future prospectives in pain management and beyond. Expert Opin Ther Targets. – 2003. – 7 (2):249–63. 10. Cheng H.Y., Pitcher G.M., Laviolette S.R., et al. DREAM is a critical transcriptional repressor for pain modulation. Cell. – 2002. – 108 (1):31–43. 11. Cox J.J., Reimann F., Nicholas A.K., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. – 2006. – 444 (7121):894–8. 12. University of Michigan Health System. Gene therapy for chronic pain enters first human trial. – 2008. Available at: http://www2.med. umich.edu/prmc/media/newsroom/details.cfm?ID=638 13. Max M.B., Stewart W.F. The molecular epidemiology of pain: A new discipline for drug discovery. Nat Rev Drug Discov. – 2008. – 7 (8):647–58. 14. Zozulya A.A., Gabaeva M.V., Sokolov O.Y., Surkina I.D., Kost N.V. Personality, coping style, and constitutional neuroimmunology. J Immunotoxicol. – 2008. – 5 (2):221–5. 15. Van Damme S., Crombez G., Eccleston C. Coping with pain: A motivational perspective. Pain. – 2008. – 139 (1):1–4. 16. Finestone H.M., Alfeeli A., Fisher W.A. Stress-induced physiologic changes as a basis for the biopsychosocial model of chronic musculoskeletal pain: A new theory? Clin J Pain. – 2008. – 24 (9):767–75. 17. Eccleston C., Crombez G. Worry and chronic pain: A misdirected problem solving model. Pain. – 2007. – 132 (3):233–6. 18. Stein C., Clark J.D., Oh U., et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev. – 2009. – 60 (1):90–113. 19. Portenoy R.K., Foley K. Chronic use of opioid analgesics in nonmalignant pain: Report of 38 cases. Pain. – 1986. – 25 (2):171–86. 20. Foley K. Opioids and chronic neuropathic pain. N Engl J Med. –
№6 январь – март 2010
2003. – 348 (13):1279–81. 21. Portenoy R.K., Bennet D.S., Rauck R., et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain. – 2006. – 7 (8):583–91. 22. Guindon J., Walczak J., Beaulieu P. Recent advances in the pharmacological management of pain. Drugs. – 2007. – 67 (15):2121–33. 23. Foletti A., Durrer A., Buchser E. Neurostimulation technology for the treatment of chronic pain: A focus on spinal cord stimulation. Expert Rev Med Devices. – 2007. – 4 (2):201–14. 24. Coffey R.J., Lozano AM. Neurostimulation for chronic noncancer pain: An evaluation of the clinical evidence and recommendations for future trial designs. J Neurosurg. – 2006. – 105 (2):175–89. 25. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. – 2009. – 10 (2):113–30. 26. Morone N.E., Greco C.M. Mind-body interventions for chronic pain in older adults: A structured review. Pain Med. – 2007. – 8 (4):359–75. 27. Owens M.K., Ehrenreich D. Literature review of nonpharmacologic methods for the treatment of chronic pain. Holist Nurs Pract. – 1991. – 6 (1):24–31. 28. Barnes P.M., Bloom B., Nahin R.L. Complementary and Alternative Medicine Use among Adults and Children: United States, 2007. Hyattsville, MD: National Health Statistics Report. December 10, 2008. Available at: http://nccam.nih.gov/news/2008/nhsr12.pdf (accessed May 20, 2009). 29. White A, Tough E, Cummings M. A review of acupuncture clinical trials indexed during. – 2005. Acupunct Med. – 2006. – 24 (1):39–49. 30. Lippe P.M. An apologia in defense of pain medicine. Clin J Pain. – 1998. – 14 (3):189–90. 31. Basbaum A.I., Julius D. Toward better pain control. Sci Am. – 2006. – 294 (6):60–7. 32. Apkarian A.V., Sosa Y., Sonty S., et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. – 2004. – 24 (46):10410–15. 33. American Board of Pain Medicine. What is an algiatrist? Pain Med. – 2008. – 5 (1):2.44 Dubois MY. President’s message: ABPM developments and initiatives. Pain Med. – 2008. – 5(1):1. 34. Gallagher R.M., Verma S. Mood and anxiety disorders in chronic pain. In: Dworkin RH, Breitbart WS, eds. Psychosocial Aspects of Pain: A Handbook for Health Care Providers. Seattle, WA: IASP Press. – 2004:139–78. 35. Lippe P.M. Conceptual construct of the specialty of pain medicine. Clin J Pain. – 1997. – 13 (3):183–5. 36. Lippe P.M. Pain medicine: Coming of age: Decade of pain control and research. Presented at the Annual Meeting, American Academy of Pain Medicine, Orlando, FL, March 4. – 2004. 37. Gallagher R.M., Lippe P.M. Pain Medicine Position Paper. Pain Medicine. – v. 10. – n. 6. – 2009. – 972–996. 38. Desirable Characteristics for Pain Treatment Facilities.